Opko Health Inc (OPK) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $1.64 (+1.23%), Market cap $0.97B, 52-week low–high $1.10 ~ $1.58.
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration
Financial statements, price targets, institutional (13F) holdings and related news for Opko Health Inc are updated in real time on BlackAll Trade.
Opko Health Inc trades at $1.64 (+1.23%). Real-time quotes and charts are available on BlackAll Trade.
Opko Health Inc has a market cap of about $0.97B.
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnosti